Clinical management of cutaneous adverse events in patients on targeted anticancer therapies and immunotherapies: a national consensus statement by the Spanish Academy of Dermatology and Venereology and the Spanish Society of Medical Oncology
Cristina Grávalos Castro, Onofre Sanmartín Jiménez, Alfonso Gúrpide Ayarra, Agustín España Alonso, Margarita Majem, Hae Jin Suh Oh, Isabel Aragón Manrique, Sonia Segura, Carmen Beato Zambrano, Rafael Botella Estrada
págs. 556-571
Anti-tumor effect of endostatin in a sleep-apnea mouse model with tumor
Xiao-Bin Zhang, Y.-Y. Yang, Y. Zeng, H.-Q. Zeng, B.-B. Fu, C.-Y. Ko, X. Luo, Y.-P. Du, L.-D. Chen, Y.-T. Lai, Y. Wu
págs. 572-581
Re-irradiation of recurrent glioblastoma as part of a sequential multimodality treatment concept
Elisabeth Bräutigam, C. Lampl, C. Track, Carsten Nieder, J. Pichler, Josef Hammer, Hans Geinitz
págs. 582-587
págs. 588-595
págs. 596-606
Maria Roch, Almudena Zapatero Laborda, Pablo Castro Tejero, D. Büchser García, L. Pérez, D. Hernández, C. Ansón, Margarita Chevalier, Feliciano García-Vicente
págs. 607-614
Status of hydration assessed by bioelectrical impedance analysis: a valuable predictive factor for radiation-induced oral mucositis in head and neck cancer patients
Anna Brzozowska, R. Mlak, P. Gołębiowski, T. Małecka-Massalska
págs. 615-620
Patient, tumor, and healthcare factors associated with regional variability in lung cancer survival: a Spanish high-resolution population-based study
Miguel Rodríguez Barranco, E. Salamanca Fernández, M.L. Fajardo Rivas, Eloísa Bayo Lozano, Daysis Yoe Ling Chang-Chan, José Expósito Hernández, C. García, J. Tallón, P. Minicozzi, M. Sant, D. Petrova, M. Ángel Luque Fernández, María José Sánchez Pérez
págs. 621-629
Patricia Helena Pecora Liberman, María Valéria Schmidt Goffi Gómez, Christiane Schultz, P. L. Jacob, C. A. A. de Paula, E. L. Sartorato, G. T. Torrezan, E. N. Ferreira, D.M. Carraro
págs. 630-635
Antigen-loaded dendritic cells triggers a specific cytotoxic T lymphocytes immune response against hepatocellular carcinoma: in vitro study
N. E. El-Ashmawy, E. A. El-Zamarany, E. G. Khedr, H. A. El-Bahrawy, O. A. El-Feky
págs. 636-645
Additional malignancies in patients with gastrointestinal stromal tumors (GIST): incidence, pathology and prognosis according to a time of occurrence-based classification
Juan Ángel Fernández Hernández, Vicente Olivares Ripoll, A. J. Gómez Ruiz, Belén Ferri Ñiguez, María Dolores Frutos Bernal, Teresa Soria Cogollos, Gloria Torres Salmerón, Pascual Parrilla Paricio
págs. 646-655
Optimization of surgical treatment of advanced ovarian cancer: a Spanish expert perspective
Lucas Minig, F.J. de Santiago García, S. Domingo del Pozo, Antonio Gil Moreno, Sergio Martínez Román, Analia Rodríguez Garzotto, Luis Chiva de Agustín
págs. 656-664
págs. 665-673
The clinicopathological and prognostic value of programmed death-ligand 1 in colorectal cancer: a meta-analysis
X. Ni, X. Sun, D. Wang, Y. Chen, Y. Zhang, W. Li, L. Wang, Jian Suo
págs. 674-686
Correction to: SEOM clinical guideline for treatment of kidney cancer (2017)
Enrique Gallardo-Díaz, María José Méndez Vidal, José Luis Pérez Gracia, Juan Manuel Sepúlveda Sánchez, Marc Campayo Guillaumes, Isabel Chirivella González, Xavier García del Muro Solans, Aránzazu González del Alba Baamonde, Enrique Grande Pulido, Cristina Suárez
págs. 692-693
© 2001-2024 Fundación Dialnet · Todos los derechos reservados